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also excluded. A total of 23 patients were identified for this 
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The study group comprised 23 children: 12 male and 
female, 6black and 17 white. The age at prese 
from 1 day to 16 years (mean 72.7 f 71.1 
patients were <2 years of age at presentati 
>2 years of age. The follow-up eriod ran 
months (mean 42.7 + 55.2). All patients pres 
similar symptoms of circulatory congesti 
heart failure, cardiomegdy on chest radiograph and left 
ventricular dysfunction by e~ho~ardiography. Two patients 
were brothers (Cases 11 and t-2). 
81990 by the American College of Cardiology 073s1097/9Q/$3.50 
190 CHEN ET AL. 
CONGESTIVE CARDIOMYOPATHY IN CHILDREN 
JACC Vol. 15, No. 1 
January I : 189-93 
Table 1. Cfinicaf Summary of 23 Children With Congestive Cardiomyopathy 
ECG 
..- Hoiter CT LVSF 
Case Age Early Late KG f%‘o) (%) 
- 
Group 1 (<2 years at presentation) 
Biopsy Autopsy 
FOliWUp 
Years Outcome 
1 10 mo LVH,TWC NL None 60.5 14.3 L 
2 22 mo LowRandT NE None 59.3 11.0 L 
3 3.5 mo LVH,TWC Same None 65.0 I2 EFE 1.7 D 
4 0.5 mo Infarct NL None 68.6 25 5.5 L 
5 0.1 mo RVH,TWC NL None 56.5 26 1.5 L 
6 21 mo Low R and T NL None 61.1 I8 2.5 L 
7 5 mo WPW WPW SVT 63.3 8 EFE EFE 1.0 D 
8 3 mo LVH.TWC Same NL 68.2 8 EFE 0.4 D 
9 0.1 mo infarct Same NL 64.0 I5 EFE 0.3 D 
IO IO mo Low R and T Same NL 63.6 13 Myocarditis 0.1 D 
Group 2 (>2 years of age) 
II 7.6 yr RAH LVH.TWC None 63.4 
I2 11.2 yr BAH LVH.TWC 55.0 
13 2.2 yr RAKTWC NL 
14 14 yr BAH.RVH.. .’ BAHCVH 
15 10.8 yr BAH,LVH.TWC Same 
None 
None 
I”,2 
AV block 
None 
PVC,VT 
PVC, couplet. 
PAC+ SVT 
None 
PVC. couplet, 
atrial Rut/fib 
NL 
61.8 
56.3 
68.9 
8 
12 
16 14.8 yr BAH.RVH BAH.LVH 
17 14.6 yr LVH NL 
18 12.5 yr Low R,TWC NL 
66.1 14 
67.0 14 
61.0 21 
19 7.1 yr Low R.TWC 
20 7.8 yr Low R.TWC 
NL 61.4 16 
62.5 23 
21 16 yr TWC NL 62.5 29 
22 2.7 yr BAH.LVH.TWC Same None 58.8 13 
23 13.7 yr Low R.TWC Same PVC, VT 65.0 14 
Myocarditis 
Myocarditis 
Myocarditis 
infiltrate and 
fibrosis 
Hypertrop;ry and 
fibrosis 
Hypetirophy and 
fibrosis 
Hypertrophy and 
fibrosis 
Familial 12.1 D 
cardiomyopaiity 
Familial 2.2 D 
cardiomyopathy 
hi.3 z 
EFE 0.2 D 
4.0 D 
0.2 D 
3.5 L 
2.0 L 
I.5 L 
2.0 L 
1.5 L 
0.2 D 
0.6 L 
BAH = biatrial hypertrophy: CT = cardiothoracic ratio; D = died: EFE = endocardial fibroelastosis: Flut/fib = flutter/fibrillation; L = lived; LVH = left 
ventricular hypertrophy: LVSF = left ventricular shortening fraction: NL = normal: R = R wave; RAH = right atria! hypertrophy; RVH = right ventricular 
hypertrophy: SVT = supraventricular tachycardia: T = T wav e; TWC = T wave changes: VT = ventricular tachycardia; WPW = Wolff-Parkinson-White 
syndrome. I”.Z” AV block = 1st and 2nd degree atrioventricular block. 
Ekctroeardkgraphy (Table 1). The ECG studies at pre- 
sentation disclosed low QRS voltage with T wave changes in 
seven patients and left ventricular hypertrophy with ST 
segment and T wave changes infive. Two patients had EC6 
changes uggestive of acute myocardial infarction. Left 
ventricular hypertrophy without T wave anomaly was seen 
in one patient, and right ventricular hypertrophy was present 
in three. Three patients had right atrial or biatrial enlarge- 
ment; one had only mild T wave changes and one had 
Wolff-Parkinson-White syndrome. Two patients presented 
with frequent premature v ntricular complexes znd a short 
burst of ventricular tachycardia. Two p&;lrib &IO had a low 
voltage QRS complex subsequerrtly had left ventricular 
hypertrophy during follow-ap. 
Ttvr patients tinderwent 24 h Halter monitor recordings; 5 
of the 10 had significant arrhythmias. Two patients had 
ventricular tachycardia and polymorphic premature v ntric- 
ular complexes; one patient had ventricular couplets and a 
short run of supraventricular t chycardia; one patient with 
Wolff-Parkinson-White syndrome had supraventricular 
tachycardia and one patient had atria1 flutter/fibrillation with 
ventricular couplets. These EC6 findings were distributed 
evenly among survivors and nonsurvivors. 
adiogmphy (Fig. 1). All 23 patients had cardiomegaly 
on chest radiography, with pulmonary congestion and pleu- 
ral eiTusion. The mean oardiothoracic ratio was 62.4% at 
presentation: in survivors, it was 62.3 -t 3.3% and in 
nonsurvivors it was 63.0 f 4.5% (p > 0.05). At 6 month 
and fibrosis in three. In two pat 
were obese (body weight ~2 S 
~y~~ro~~y and fibrosis were evl 
Aumpsy was per~~r~~~ in seven parients. Four patients 
. Left ventricular sho 
s in nine survivors 
(broken lines). 
fraction (LV SF.1 on echocar- 
Bined and nine nonsurvivors 
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Fii 3. Survival rates in the entire study group (t es) (n = 
23), younger group diagnosed before 2 years of age Wsed circles) 
(n = 10) and older group diagnosed after 2years of age (open circles) 
(n = 13). 
quinidine and was treated with amiodarone, which was 
continued until he received acardiac transplant. 
Two patients (Cases 15 and 16) received immunosuppres- 
sive therapy based on thefinding of lymphocytic myocarditis 
OR endomyocardiul biopsy. One patient died during the 
therapy and one failed to show improvement and eventually 
disd. Two patients underwent cardiac transplantation; e 
patient (Case 7) received two transplants and died after 
rupture of the aortic suture line from chronic mediastinitis 
subsequent to the second transplant. One patient (Case 20) 
improved and is well 12 months after transplantation. 
ity (Fig. 3). The overall mortality rate was 47.8% 
(11 of 23). The I year mortality rate was 30.4% (7 of 23) and 
the 5 year mortality rate was 43.5% (10 of 23). Patients who 
presented at <2 years of age had a 50% mortality rate (5 of 
10) and those who presented at>2 years had a mortality rate 
of 46.2% (6 of 13). Seven patients died from chronic heart 
failure and four died suddenly while in the hospital (Cases 3, 
7, 10 and 14). One patient died from massive hemorrhages 
after an infectious complication i  the postcardiac transplant 
period; one developed bradycardia and died after choking on 
medicine; another had bradycardia and died after attempted 
arterial puncture for blood gas analysis. The fourth patient 
died suddenly, and bedside monitoring showed ventricular 
fibrillation. 
iscussion 
Age of onset and arrhythmia. Previous tudies (3,4,6,7) of
congestive cardiomyopathy ave shown that there were 
prognostic factors that could predict he outcome in patients 
with this illness; these factors included age at onset and 
presence ofarrhythmias. The higher mortality rate reported 
in older patients was not present in our patients. The role of 
arrhythmias in survival could not be judged in our small 
series. Ventricular arrhythmias increase the mortality rate 
and risk of sudden death in adult patients with congestive 
cardiomyopathy (67). We did not obtain 24 h ECG monitor- 
ing in all patients; thus, the exact prevalence of ventricular 
arrhythmias could not be evaluated. However, two patients 
presenting with ventricular tacbycardia n 
with ventricular couplets and atrial arrhyth 
IL& ve~tric~~a~ fun~ion an 
indicated that he severity of left 
an important prognostic factor. Patients with a very low 
shortening fraction and persistent cardiomegaly had a 
mortality rate than did those presenting with milder 
tion in the shortening fraction and normalization of the 
shortening fraction and cardi acic ratio at follow-up 
study. This observation was si to that of other authors 
(8,9) who noted that poor prognosis was associated witb a 
opsy was useful in managing our patieits (10). It was helpful 
in identifying those who could sibly benefit from immu- 
nosuppressive therapy. The e t of various myocardial 
changes on survival is difficult o evaluate because of the 
small number of patients in each subgroup. Fifteen patients 
had histologic examination; all four with endocardial fi- 
broelastosis and the two with familial cardiomyopathy 
Patients with myocarditis or hypertrophy and fibrosis 
survive or die. The histologic findings of endocardial fi- 
broelastosis carried a poor prognosis. It 
end-stage pathologic response of the endo 
stress on the myocardium and may be cause 
different diseases (11). Some patients with acute myocarditis 
or myocardial injury have the potential to improve and 
recover; however, those who do not recover could progress 
to have the changes of e~docardia~ fibroelastosis. Familial 
cardiomyopathy carried a poor prognosis in our patients. 
Two brothers from one family had cardiomyopathy with a 
prolonged clinical course and died. Their mother developed 
cardiomyopathy later. They most likely had X-linked famil- 
ial cardiomyopathy, although no electron microscopic study 
was done to document the reported mitochondrial abnormal- 
ities (12,13). 
We believe that patients with dilated cardiomyopathy 
who have poor prognostic factors hould be identified early 
and if their condition does not improve, they can be consid- 
ered for possible cardiac transplantation. 
Conclusions. The clinical presentation of children with 
congestive cardiomyopathy was very similar and their pre- 
sentation did not predict histologic hanges. The initial 
cardiothoracic ratio by chest radiography in survivors and 
nonsurvivors was similar; however, left ventricular shorten- 
ing fraction was lower in nonsurvivors. The survivors had a 
mean shortening fraction of 20.7% compared with 11.5% in 
nonsurvivors. The 1 year survival rate was 70% and the 5 
year survival rate was 56%; the overall mortality rate was 
47.8%. Arrhythmias were seen in both survivors and non- 
survivors; age and gender were not different in the two 
groups. Very low left ventricular shortening fraction, famil- 
ial cardiomyopathy and endocardial fibroelastosis indicated 
a poor prognosis. 
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